Pablo J. Cagnoni - 19 Aug 2026 Form 4 Insider Report for INCYTE CORP (INCY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 17:15:28 UTC
Prior SEC filing
14 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Feeney, Attorney-In-Fact

Key filing fact

Pablo J. Cagnoni filed Form 4 for INCYTE CORP (INCY) on 20 Aug 2026.

Key facts

  • This page summarizes Pablo J. Cagnoni's Form 4 filing for INCYTE CORP (INCY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2026, 17:15.

Change

  • Previous filing in this sequence was filed on 14 Aug 2026.
  • Current net transaction value: -$1,356,174.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001205703 Primary reporting owner

CAGNONI PABLO J

Relationship
President, Global Head of R&D
Address
1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Signature date
20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Sale

Transaction value
$1,356,174
Shares
-10,801
Change %
-5.6%
Price
$125.56
Shares after
183,200
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .